Skip to main content
Top
Published in: Drugs & Aging 7/2008

01-07-2008 | Leading Article

Drug-Induced Urinary Incontinence

Authors: Peter Tsakiris, Matthias Oelke, Professor Martin C. Michel

Published in: Drugs & Aging | Issue 7/2008

Login to get access

Abstract

Physiological urinary continence depends on many factors that are potentially vulnerable to adverse drug effects, which may lead to incontinence. In principle, drugs could cause incontinence by lowering bladder outlet resistance and/or by increasing intravesical pressure, which disrupts the normal pressure relationship between the bladder and urethra and leads to urinary leakage; other possibilities include disturbances of central nervous control of voiding or an overproduction of urine. While many drug groups could theoretically induce urinary incontinence based upon pathophysiological considerations, evidence demonstrating a cause-effect relationship between drug usage and incontinence is sparse. Drug classes in which induction of incontinence has been proposed include α1-adrenoceptor antagonists, antipsychotics, benzodiazepines, antidepressants and hormone replacement therapy in postmenopausal women. However, other drug classes are not innocent in terms of causing urinary incontinence and physicians are well advised to closely monitor patients for the occurrence of incontinence after new prescriptions and/or major dosage changes.
Literature
1.
go back to reference Anger JT, Saigal CS, Stothers L, et al. The prevalence of urinary incontinence among community dwelling men: results from the National Health and Nutrition Examination Survey. J Urol 2006 Nov; 176: 2103–8PubMedCrossRef Anger JT, Saigal CS, Stothers L, et al. The prevalence of urinary incontinence among community dwelling men: results from the National Health and Nutrition Examination Survey. J Urol 2006 Nov; 176: 2103–8PubMedCrossRef
2.
go back to reference Anger JT, Saigal CS, Litwin MS, et al. The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol 2006; 175: 601–4PubMedCrossRef Anger JT, Saigal CS, Litwin MS, et al. The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey. J Urol 2006; 175: 601–4PubMedCrossRef
3.
go back to reference Morrison A, Levy R. Fraction of nursing home admissions attributable to urinary incontinence. Value Health 2006; 9: 272–4PubMedCrossRef Morrison A, Levy R. Fraction of nursing home admissions attributable to urinary incontinence. Value Health 2006; 9: 272–4PubMedCrossRef
4.
go back to reference Saadoun K, Ringa V, Fritel X, et al. Negative impact of urinary incontinence on quality of life, a cross-sectional study among women aged 49–61 years enrolled in the GAZEL cohort. Neurourol Urodyn 2006; 25: 696–702PubMedCrossRef Saadoun K, Ringa V, Fritel X, et al. Negative impact of urinary incontinence on quality of life, a cross-sectional study among women aged 49–61 years enrolled in the GAZEL cohort. Neurourol Urodyn 2006; 25: 696–702PubMedCrossRef
5.
go back to reference Michel MC, Oelke M, Peters SLM. The neuro-urological connection. Eur Urol Suppl 2005; 4: 18–28CrossRef Michel MC, Oelke M, Peters SLM. The neuro-urological connection. Eur Urol Suppl 2005; 4: 18–28CrossRef
6.
go back to reference Bannowsky A, Juenemann KP. Innervation and function of the female urinary bladder and urethra. EAU Update Series 2003; 1: 120–7CrossRef Bannowsky A, Juenemann KP. Innervation and function of the female urinary bladder and urethra. EAU Update Series 2003; 1: 120–7CrossRef
8.
go back to reference Resnick NM, Baumann M, Scott M. Risk factors for incontinence in nursing home: a multivariate study. Neurourol Urodyn 1988; 7: 274–6 Resnick NM, Baumann M, Scott M. Risk factors for incontinence in nursing home: a multivariate study. Neurourol Urodyn 1988; 7: 274–6
9.
go back to reference Scientific Committee of the First International Consultation on Incontinence. Assessment and treatment of urinary incontinence. Lancet 2000; 355: 2153–8CrossRef Scientific Committee of the First International Consultation on Incontinence. Assessment and treatment of urinary incontinence. Lancet 2000; 355: 2153–8CrossRef
10.
go back to reference Harrison NW, Whitfield HN, Williams DI. The place of alpha-blocking drugs in the treatment of children with neuropathic bladders. Urol Int 1977; 32: 224–31PubMedCrossRef Harrison NW, Whitfield HN, Williams DI. The place of alpha-blocking drugs in the treatment of children with neuropathic bladders. Urol Int 1977; 32: 224–31PubMedCrossRef
11.
go back to reference Mathew TH, McEwan J, Rohan A. Urinary incontinence secondary to prazosin. Med J Aust 1988; 148: 305–6PubMed Mathew TH, McEwan J, Rohan A. Urinary incontinence secondary to prazosin. Med J Aust 1988; 148: 305–6PubMed
12.
go back to reference Wall LL, Addison WA. Prazosin induced stress incontinence. Obstet Gynaecol 1990; 75: 558–60 Wall LL, Addison WA. Prazosin induced stress incontinence. Obstet Gynaecol 1990; 75: 558–60
13.
go back to reference Menefee SA, Chesson R, Wall LL. Stress urinary incontinence due to prescription medications: alpha-blockers and angiotensin converting enzyme inhibitors. Obstet Gynecol 1998; 91: 853–4PubMedCrossRef Menefee SA, Chesson R, Wall LL. Stress urinary incontinence due to prescription medications: alpha-blockers and angiotensin converting enzyme inhibitors. Obstet Gynecol 1998; 91: 853–4PubMedCrossRef
14.
go back to reference Thien T, Delaere KP, Debruyne FM, et al. Urinary incontinence caused by prazosin. BMJ 1978; 1: 622–3PubMedCrossRef Thien T, Delaere KP, Debruyne FM, et al. Urinary incontinence caused by prazosin. BMJ 1978; 1: 622–3PubMedCrossRef
15.
go back to reference Kiruluta GH, Mercer AR, Winsor GM. Prazosin as cause of urinary incontinence. Urology 1981; 18: 618–9PubMedCrossRef Kiruluta GH, Mercer AR, Winsor GM. Prazosin as cause of urinary incontinence. Urology 1981; 18: 618–9PubMedCrossRef
16.
go back to reference Srinivasan V, Blackford HN. Genuine stress incontinence induced by prazosin. Br J Urol 1993; 72: 510PubMedCrossRef Srinivasan V, Blackford HN. Genuine stress incontinence induced by prazosin. Br J Urol 1993; 72: 510PubMedCrossRef
17.
go back to reference Dwyer PL, Teele JS. Prazosin: a neglected cause of stress incontinence. Obstet Gynaecol 1992; 79: 117–21 Dwyer PL, Teele JS. Prazosin: a neglected cause of stress incontinence. Obstet Gynaecol 1992; 79: 117–21
18.
go back to reference Donker PJ, Ivanovici F, Noach EL. Analyses of the urethral pressure profile by means of electromyography and the administration of drugs. Br J Urol 1972; 44: 180–93PubMedCrossRef Donker PJ, Ivanovici F, Noach EL. Analyses of the urethral pressure profile by means of electromyography and the administration of drugs. Br J Urol 1972; 44: 180–93PubMedCrossRef
19.
go back to reference Marshall HJ, Beevers DG. Alpha-adrenergic blockade and urinary incontinence. J Hypertens 1993; 11: 1152–3CrossRef Marshall HJ, Beevers DG. Alpha-adrenergic blockade and urinary incontinence. J Hypertens 1993; 11: 1152–3CrossRef
20.
go back to reference Marshall HJ, Beevers DG. β-Adrenoceptor blocking drugs and female urinary incontinence: prevalence and reversibility. Br J Clin Pharmacol 1996; 42: 507–9PubMedCrossRef Marshall HJ, Beevers DG. β-Adrenoceptor blocking drugs and female urinary incontinence: prevalence and reversibility. Br J Clin Pharmacol 1996; 42: 507–9PubMedCrossRef
21.
go back to reference Vrydag W, Michel MC. Tools to study ß3-adrenoceptors. Naunyn-Schmiedebergs Arch Pharmacol 2007; 374: 385–98PubMedCrossRef Vrydag W, Michel MC. Tools to study ß3-adrenoceptors. Naunyn-Schmiedebergs Arch Pharmacol 2007; 374: 385–98PubMedCrossRef
22.
go back to reference Berrios GE. Temporary urinary incontinence in the acute psychiatric patient without delusion or dementia. Br J Psychiatr 1986; 149: 224–7CrossRef Berrios GE. Temporary urinary incontinence in the acute psychiatric patient without delusion or dementia. Br J Psychiatr 1986; 149: 224–7CrossRef
23.
go back to reference Van Putten T, Malkin MD, Weiss MS. Phenothiazine-induced stress incontinence. J Urol 1973; 104: 625–6 Van Putten T, Malkin MD, Weiss MS. Phenothiazine-induced stress incontinence. J Urol 1973; 104: 625–6
24.
go back to reference Ambrosini PJ. A pharmacologic paradigm for urinary incontinence and enuresis. J Clin Psychopharmacol 1984; 4: 247–53PubMed Ambrosini PJ. A pharmacologic paradigm for urinary incontinence and enuresis. J Clin Psychopharmacol 1984; 4: 247–53PubMed
26.
go back to reference Ambrosini PJ, Nurnberg HG. Enuresis and incontinence occurring with neuroleptics. Am J Psychol 1980; 137: 1278–9 Ambrosini PJ, Nurnberg HG. Enuresis and incontinence occurring with neuroleptics. Am J Psychol 1980; 137: 1278–9
27.
go back to reference Nurnberg HG, Ambrosini PJ. Urinary incontinence in patients receiving neuroleptics. J Clin Psychol 1979; 40: 271–4 Nurnberg HG, Ambrosini PJ. Urinary incontinence in patients receiving neuroleptics. J Clin Psychol 1979; 40: 271–4
28.
go back to reference Clozaril (clozapine). In: The Physicians’ Desk Reference. 53rd ed. Montvale (Nj): Medical Economics, 1999: 2004–8 Clozaril (clozapine). In: The Physicians’ Desk Reference. 53rd ed. Montvale (Nj): Medical Economics, 1999: 2004–8
29.
go back to reference Fuller MA, Borovicka MC, Jaskiw GE, et al. Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. J Clin Psychiatr 1996; 57: 514–8CrossRef Fuller MA, Borovicka MC, Jaskiw GE, et al. Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. J Clin Psychiatr 1996; 57: 514–8CrossRef
30.
go back to reference Lin CC, Bai YM, Chen JY, et al. A retrospective study of clozapine and urinary incontinence in Chinese in-patients. Acta Psychiatr Scand 1999; 100: 158–61PubMedCrossRef Lin CC, Bai YM, Chen JY, et al. A retrospective study of clozapine and urinary incontinence in Chinese in-patients. Acta Psychiatr Scand 1999; 100: 158–61PubMedCrossRef
31.
go back to reference Warner JP, Harvey CA, Barnes TR. Clozapine and urinary incontinence. Int Clin Psychopharmacol 1994; 9: 207–9PubMedCrossRef Warner JP, Harvey CA, Barnes TR. Clozapine and urinary incontinence. Int Clin Psychopharmacol 1994; 9: 207–9PubMedCrossRef
32.
go back to reference Vokas CS, Steele VM, Norris JI, et al. Incidence of risperidone induced incontinence [abstract]. Schizophr Res 1997; 24: 267CrossRef Vokas CS, Steele VM, Norris JI, et al. Incidence of risperidone induced incontinence [abstract]. Schizophr Res 1997; 24: 267CrossRef
33.
go back to reference Vernon L, Fuller M, Hattab H, et al. Olanzapine-induced urinary incontinence: treatment with ephedrine. J Clin Psychiatry 2000; 61: 601–2PubMedCrossRef Vernon L, Fuller M, Hattab H, et al. Olanzapine-induced urinary incontinence: treatment with ephedrine. J Clin Psychiatry 2000; 61: 601–2PubMedCrossRef
34.
go back to reference Sagar R, Varghese ST, Balhara YP. Olanzapine-induced double incontinence. Indian J Med Sci 2005; 59: 163–4PubMedCrossRef Sagar R, Varghese ST, Balhara YP. Olanzapine-induced double incontinence. Indian J Med Sci 2005; 59: 163–4PubMedCrossRef
35.
go back to reference Vera PL, Miranda-Sousa A, Nadelhaft I. Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats. BMC Pharmacol 2001; 1: 4PubMedCrossRef Vera PL, Miranda-Sousa A, Nadelhaft I. Effects of two atypical neuroleptics, olanzapine and risperidone, on the function of the urinary bladder and the external urethral sphincter in anesthetized rats. BMC Pharmacol 2001; 1: 4PubMedCrossRef
36.
go back to reference Landi F, Cesari M, Russo A, et al. Benzodiazepines and the risk of urinary incontinence in frail older persons living in the community. Clin Pharmacol Ther 2002; 72: 729–34PubMedCrossRef Landi F, Cesari M, Russo A, et al. Benzodiazepines and the risk of urinary incontinence in frail older persons living in the community. Clin Pharmacol Ther 2002; 72: 729–34PubMedCrossRef
37.
38.
go back to reference Votolato NA, Stern S, Caputo RM. Serotonergic antidepressants and urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2000; 11: 386–8PubMedCrossRef Votolato NA, Stern S, Caputo RM. Serotonergic antidepressants and urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2000; 11: 386–8PubMedCrossRef
39.
go back to reference Cavanaugh GL, Martin RE, Stenson MA, et al. Venlafaxine and urinaryincontinence: possibleassociation [letter]. Ann Pharmacother 1997; 31: 372PubMed Cavanaugh GL, Martin RE, Stenson MA, et al. Venlafaxine and urinaryincontinence: possibleassociation [letter]. Ann Pharmacother 1997; 31: 372PubMed
40.
go back to reference Movig KL, Leufkens HG, Belitser SV, et al. Selective serotonin reuptake inhibitor-induced urinary incontinence. Pharmacoepidemiol Drug Saf 2002; 11: 271–9PubMedCrossRef Movig KL, Leufkens HG, Belitser SV, et al. Selective serotonin reuptake inhibitor-induced urinary incontinence. Pharmacoepidemiol Drug Saf 2002; 11: 271–9PubMedCrossRef
41.
go back to reference Katofiasc MA, Nissen J, Audia JE, et al. Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats. Life Sci 2002; 71: 1227–36PubMedCrossRef Katofiasc MA, Nissen J, Audia JE, et al. Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats. Life Sci 2002; 71: 1227–36PubMedCrossRef
42.
go back to reference Michel MC, Oelke M. Duloxetine in the treatment of stress urinary incontinence. Womens Health 2005; 1: 345–8 Michel MC, Oelke M. Duloxetine in the treatment of stress urinary incontinence. Womens Health 2005; 1: 345–8
43.
go back to reference Griebling TL, Nygaard IE. The role of estrogen replacement therapy in the management of urinary incontinence and urinary tract infection in postmenopausal women. Endocrinol Metab Clin North Am 1997; 26: 347–60PubMedCrossRef Griebling TL, Nygaard IE. The role of estrogen replacement therapy in the management of urinary incontinence and urinary tract infection in postmenopausal women. Endocrinol Metab Clin North Am 1997; 26: 347–60PubMedCrossRef
44.
go back to reference Moehrer B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women. Cochrane Database Syst Rev 2003; (2): CD001405 Moehrer B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women. Cochrane Database Syst Rev 2003; (2): CD001405
45.
go back to reference Grodstein F, Lifford K, Resnick NM, et al. Postmenopausal hormone therapy and risk of developing urinary incontinence. Obstet Gynecol 2004; 103: 254–60PubMedCrossRef Grodstein F, Lifford K, Resnick NM, et al. Postmenopausal hormone therapy and risk of developing urinary incontinence. Obstet Gynecol 2004; 103: 254–60PubMedCrossRef
46.
go back to reference Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005; 293: 935–48PubMedCrossRef Hendrix SL, Cochrane BB, Nygaard IE, et al. Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005; 293: 935–48PubMedCrossRef
47.
go back to reference Jackson S, James M, Abrams P. The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence. BJOG 2002; 109: 339–44PubMedCrossRef Jackson S, James M, Abrams P. The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence. BJOG 2002; 109: 339–44PubMedCrossRef
48.
go back to reference Diokno AC, Brown MD, Herzog AR. Relationship between use of diuretics and continence status in the elderly. Urology 1991; 38: 39–42PubMedCrossRef Diokno AC, Brown MD, Herzog AR. Relationship between use of diuretics and continence status in the elderly. Urology 1991; 38: 39–42PubMedCrossRef
49.
go back to reference Fantl JA, Wyman JF, Wilson M, et al. Diuretics and urinary incontinencein community-dwelling women. Neurourol Urodyn 1990; 9: 25–34CrossRef Fantl JA, Wyman JF, Wilson M, et al. Diuretics and urinary incontinencein community-dwelling women. Neurourol Urodyn 1990; 9: 25–34CrossRef
50.
go back to reference Ouslander JG, Uman GC, Urman HN, et al. Incontinence among nursing home patients: clinical functional correlates. J Am Geriatr Soc 1987; 35: 324–30PubMed Ouslander JG, Uman GC, Urman HN, et al. Incontinence among nursing home patients: clinical functional correlates. J Am Geriatr Soc 1987; 35: 324–30PubMed
Metadata
Title
Drug-Induced Urinary Incontinence
Authors
Peter Tsakiris
Matthias Oelke
Professor Martin C. Michel
Publication date
01-07-2008
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 7/2008
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200825070-00001

Other articles of this Issue 7/2008

Drugs & Aging 7/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.